Evidence map›Paper›PMID 33791895›Full record

ReviewJournal of assisted reproduction and genetics2021

Hormonal markers as noninvasive predictors of sperm retrieval in non-obstructive azoospermia.

Reza Zarezadeh, Amir Fattahi, Saba Nikanfar, Hajar Oghbaei, Yadollah Ahmadi, Yeganeh Rastgar Rezaei, Mohammad Nouri, Ralf Dittrich

Abstract readReview
In one paragraph

Review in Journal of assisted reproduction and genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. 2023 Canadian Urological Association guideline: Evaluation and management of azoospermia.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Reza ZarezadehDepartment of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Amir FattahiDepartment of Reproductive Biology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Saba NikanfarDepartment of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Hajar OghbaeiDepartment of Physiology, Tabriz University of Medical Sciences, Tabriz, Iran.
Yadollah AhmadiDepartment of Urology, Sina Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
Yeganeh Rastgar RezaeiStem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. yeganerastgar@gmail.com.
Mohammad NouriStem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. nourimd@yahoo.com.ORCID http://orcid.org/0000-0002-5367-9956
Ralf DittrichDepartment of Obstetrics and Gynecology, Erlangen University Hospital, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-obstructive azoospermia (NOA) is one of the leading causes of male factor infertility, which results from impaired spermatogenesis. Currently, the sole feasible therapeutic option for men with NOA to father their biologic children is sperm retrieval by testicular sperm extraction (TESE) approaches followed by an intracytoplasmic sperm injection program. Nevertheless, the rate of sperm retrieval from NOA men following TESE has remained as low as 50%, leading to a significant number of unsuccessful TESE operations. Given that TESE is associated with multiple side effects, the prediction of TESE outcome preoperatively can abolish unnecessary operations and thereby prevent NOA patients from sustaining adverse side effects. As the process of spermatogenesis is under the regulation of hormones, the hormonal profile of serum and/or seminal plasma may contain useful information about spermatogenesis status and can potentially predict the chance of sperm retrieval from NOA patients. A large body of literature is available on the predictive capability of different serum and seminal plasma hormones such as FSH, LH, testosterone, inhibin B, AMH, estradiol, prolactin, and leptin in a stand-alone basis or combinational fashion with respect to the TESE outcome. The present review aimed to evaluate the potential of these hormonal markers as noninvasive predictors of sperm retrieval in men with NOA.

Indexed as

AzoospermiaEstradiolFollicle Stimulating Hormone, HumanHormonesHumansInhibinsLeptinLuteinizing HormoneMaleProlactinSemenSpermatogenesisSperm Injections, IntracytoplasmicSperm RetrievalTestosteroneEstradiolFollicle Stimulating Hormone, HumanHormonesinhibin BInhibinsLeptinLuteinizing HormoneProlactinTestosteroneAzoospermiaBiomarkersHormonesSpermatozoaSperm retrieval

Identifiers

PMID33791895
PMCPMC8417206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.